780
Participants
Start Date
November 30, 2009
Primary Completion Date
December 31, 2011
Study Completion Date
December 31, 2011
IDP-108
Topical application once a day for 48 weeks
Vehicle
Topical application once a day for 48 weeks
Fran E. Cook-Bolden, MD, New York
DermResearchCenter of New York, Inc., Stony Brook
Skin Search of Rochester, Inc, Rochester
University of North Carolina Hospitals and School of Medicine, Chapel Hill
New Hanover Medical Research, Wilmington
Palmetto Medical Research, Mt. Pleasant
MedaPhase Inc., Newnan
Ameriderm Research, Jacksonville
FXM Research Corp., Miami
Tennessee Clinical Research Center, Nashville
Dermatology East, Germantown
South Bend Clinic, South Bend
Deaconess Clinic, Inc., Evansville
Hamzavi Dermatology, Fort Gratiot
David Fivenson, MD, Dermatology, PLLC, Ann Arbor
Madison Skin & Research, Inc., Madison
Minnesota Clinical Study Center, Fridley
DuPage Medical Group, Naperville
Burke Pharmaceutical Research, Hot Springs
Central Sooner Research, Norman
Modern Research Associates, PLLC, Dallas
Suzanne Bruce and Associates, PA The Center for Skin Research, Houston
Endeavor Clinical Trials, PA, San Antonio
DermResearch, Inc., Austin
Colorado Medical Research Center Inc, Denver
Northwest Clinical Trials Nampa, Nampa
Impact Clinical Trials, Los Angeles
Dermatology Research Associates, Los Angeles
Dermatology Specialists, Inc., Oceanside
Skin Surgery Medical Group, Inc., San Diego
Center for Clinical Research, San Francisco
Radiant Research, Santa Rosa
Oregon Medical Center, PC, Portland
Premier Clinical Research, Spokane
The Dermatology Group, P.C., Verona
Brodell Medical, Inc, Warren
Guildford Dermatology Specialists, Surrey
Dermadvances Research, Winnipeg
NewLab Clinical Research, St. John's
Lynderm Research, Inc., Markham
The Centre for Dermatology & Cosmetic Surgery, Richmond Hill
K. Papp Clinical Research, Waterloo
Windsor Clinical Research, Windsor
Beatrice Wang, MD, Westmount
Lead Sponsor
Dow Pharmaceutical Sciences
INDUSTRY